Bristol Myers Squibb (BMY) Stock Analysis | Undervalued Dividend Giant or Value Trap?

Описание: Is Bristol-Myers Squibb (BMY) a hidden gem in the stock market or just a value trap? 📉 In this video, I break down BMY’s fundamentals, cash flow, dividend yield, and valuations using my in-depth spreadsheet models. From a 14% cash flow yield to their 2024 acquisition of Karuna, there's a lot to unpack here for dividend investors and value seekers alike.

🔍 Whether you're new to investing or a seasoned dividend investor, this video gives you a full breakdown of BMY stock’s current situation. Is this Big Pharma stock a buy in 2025? Let’s find out.

✅ Don't forget to like, subscribe, and hit that bell icon for more deep dives into dividend stocks!

Here is a playlist for you!    • Stock Valuations  

#DividendStocks #BMYStock #BristolMyersSquibb #StockAnalysis #ValueInvesting #DividendInvesting #PharmaStocks #StockMarket2025 #FCFAnalysis #UndervaluedStocks

📊 Timestamps:
00:00 - Intro + Rant
00:58 - BMY Business Model
02:23 - Chart Overview
02:42 - Quick Stats
03:29 - Numbers Overview + Notes
04:35 - FCF Valuation
06:04 - Dividend Valuation
07:11 - Earnings Valuation
08:23 - Intrinsic Value
08:51 - My Thoughts
10:12 - Have A Good Day!


📜 Disclaimer: I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are just my opinions and for informational and entertainment purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. Always speak to your licenced financial advisor before investing your money. I'm just a random Swedish guy on the internet.